Study of DE-089 Ophthalmic Solution in Patients With Dry Eye

• Status: Completed
• Trial end date: 2012-04-01
• Target enrollment: 0
• Participant gender: All

Summary

Safety and efficacy of DE-089 ophthalmic solution in patients with dry eye will be evaluated in comparison with sodium hyaluronate ophthalmic solution.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Santen Pharmaceutical Co., Ltd.
• Treatments: Hyaluronic Acid; Ophthalmic Solutions; Pharmaceutical Solutions

Criteria

Inclusion Criteria:

• Those who show:

• Keratoconjunctival disorder confirmed with vital dye staining

• Abnormal Schirmer score results

Exclusion Criteria:

• Eye disease that needs therapy other than that for dry eye

• Those who need to wear contact lenses during the clinical study